OncoGenex Pharmaceuticals, Inc.Bothell, WA, United States (NASDAQ (CM): OGXI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

OncoGenex Pharmaceuticals Financial Statements

OncoGenex Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

OncoGenex Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 20.1 22.4 8.3
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (15.2) (26.3) (21.8)
Total Net Income ($ mil.) (13.1) (23.5) (21.1)
Diluted EPS (Net Income) (0.35) (0.68) (0.88)
More OncoGenex Pharmaceuticals financial information

OncoGenex Pharmaceuticals Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 0.0 0.0 7.7
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (4.0) (4.4) 1.5
Total Net Income ($ mil.) (3.8) (4.1) 1.9
Diluted EPS (Net Income) (0.10) (0.11) 0.06
More OncoGenex Pharmaceuticals financial information

OncoGenex Pharmaceuticals Stock Quote & Chart

08/20/08 14:59:40 EST • NASDAQ • 0.28 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

OncoGenex Pharmaceuticals Competitive Intelligence

Abraxis BioScience Bristol-Myers Squibb Pfizer
Annual Sales ($ mil.) 333.7 19,348.0 48,418.0
Employees -- 42,000 86,600
Market Cap ($ mil.) 2,933.3 43,230.6 131,516.8